126 related articles for article (PubMed ID: 1551096)
1. Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy.
Boone CW; Kelloff GJ; Steele VE
Cancer Res; 1992 Apr; 52(7):1651-9. PubMed ID: 1551096
[TBL] [Abstract][Full Text] [Related]
2. The natural history of intraepithelial neoplasia: relevance to the search for intermediate endpoint biomarkers.
Boone CW; Kelloff GJ; Steele VE
J Cell Biochem Suppl; 1992; 16G():23-6. PubMed ID: 1469901
[TBL] [Abstract][Full Text] [Related]
3. Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents.
Boone CW; Bacus JW; Bacus JV; Steele VE; Kelloff GJ
J Cell Biochem Suppl; 1997; 28-29():1-20. PubMed ID: 9589346
[TBL] [Abstract][Full Text] [Related]
4. Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis.
Boone CW; Kelloff GJ
Cancer Surv; 1998; 32():133-47. PubMed ID: 10489626
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
[TBL] [Abstract][Full Text] [Related]
6. Karyometry in the early detection and chemoprevention of intraepithelial lesions.
Ranger-Moore J; Alberts DS; Montironi R; Garcia F; Davis J; Frank D; Brewer M; Mariuzzi GM; Bartels HG; Bartels PH
Eur J Cancer; 2005 Sep; 41(13):1875-88. PubMed ID: 16087328
[TBL] [Abstract][Full Text] [Related]
7. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
DiGiovanni J; Rho O; Xian W; Beltràn L
Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
[TBL] [Abstract][Full Text] [Related]
8. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
[TBL] [Abstract][Full Text] [Related]
9. Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasia.
Boone CW; Kelloff GJ
J Cell Biochem Suppl; 1994; 19():10-22. PubMed ID: 7823580
[TBL] [Abstract][Full Text] [Related]
10. Diphenylmethyl selenocyanate inhibits DMBA-croton oil induced two-stage mouse skin carcinogenesis by inducing apoptosis and inhibiting cutaneous cell proliferation.
Das RK; Hossain SK; Bhattacharya S
Cancer Lett; 2005 Dec; 230(1):90-101. PubMed ID: 16253765
[TBL] [Abstract][Full Text] [Related]
11. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice.
Arbeit JM; Riley RR; Huey B; Porter C; Kelloff G; Lubet R; Ward JM; Pinkel D
Cancer Res; 1999 Aug; 59(15):3610-20. PubMed ID: 10446971
[TBL] [Abstract][Full Text] [Related]
12. Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion.
Tennenbaum T; Lowry D; Darwiche N; Morgan DL; Gartsbein M; Hansen L; De Luca LM; Hennings H; Yuspa SH
Cancer Res; 1998 Apr; 58(7):1435-43. PubMed ID: 9537245
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive effects of sarcophine-diol on skin tumor development in CD-1 mice.
Zhang X; Kundoor V; Khalifa S; Zeman D; Fahmy H; Dwivedi C
Cancer Lett; 2007 Aug; 253(1):53-9. PubMed ID: 17321042
[TBL] [Abstract][Full Text] [Related]
14. In vivo long-term effects of retinoic acid exposure in utero on induced tumours in adult mouse skin.
García-Fernández RA; Pérez-Martínez C; García-Iglesias MJ
Vet Dermatol; 2014 Dec; 25(6):538-46, e93-4. PubMed ID: 25041412
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
16. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses.
Meeran SM; Vaid M; Punathil T; Katiyar SK
Carcinogenesis; 2009 Mar; 30(3):520-8. PubMed ID: 19158151
[TBL] [Abstract][Full Text] [Related]
17. Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials.
Bostwick DG; Aquilina JW
J Cell Biochem Suppl; 1996; 25():156-64. PubMed ID: 9027613
[TBL] [Abstract][Full Text] [Related]
18. The premalignant nature of mouse skin papillomas: histopathologic, cytogenetic, and biochemical evidence.
Aldaz CM; Conti CJ
Carcinog Compr Surv; 1989; 11():227-42. PubMed ID: 2465820
[No Abstract] [Full Text] [Related]
19. Sequential studies of skin tumorigenesis in phosphoglycerate kinase mosaic mice: effect of resumption of promotion on regressed papillomas.
Reddy AL; Caldwell M; Fialkow PJ
Cancer Res; 1987 Apr; 47(7):1947-51. PubMed ID: 3102053
[TBL] [Abstract][Full Text] [Related]
20. Biomarker end-points in cancer chemoprevention trials.
Boone CW; Kelloff GJ
IARC Sci Publ; 1997; (142):273-80. PubMed ID: 9354926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
